The Effect of Erector Spinae Block for Postoperative Pain Management Cesarean Delivery Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pain
- Sponsor
- Kahramanmaras Sutcu Imam University
- Enrollment
- 56
- Locations
- 1
- Primary Endpoint
- 24-hour opioid consumption
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Erector spinae plane (ESP) block is an interfacial plane block with visceral and somatic analgesic activity at paraspinal muscles. This study aims to examine the postoperative analgesic efficacy of ESP block after cesarean section (CS) with Pfannenstiel incision under spinal anesthesia.
Detailed Description
The study included 54 patients with mild systemic disease (ASA II patients) who would undergo elective CS under spinal anesthesia. They were randomly divided into an ESP block group (Group E) and a control group (Group C). After the surgery, Group E patients underwent ultrasound-guided bilateral ESP block with 20 ml of 0.25% bupivacaine at the lateral decubitus position, while Group C received no intervention. Patients in both groups received parenteral patient-controlled analgesia. The patients' post-operative 24-hour opioid consumption, regular Visual Analogue Scale (VAS) measurements, and need for rescue analgesics were evaluated. Statistical analysis was performed using SPSS 21 program. Demographic and other data were assessed using independent samples t-test, Mann-Whitney U test, and Chi-square analysis.
Investigators
Gökçe Gişi
Assistant Professor
Kahramanmaras Sutcu Imam University
Eligibility Criteria
Inclusion Criteria
- •ASA II patients
- •18-45 years who underwent CS with Pfannenstiel incision under spinal anesthesia
- •agreed to participate in the study
Exclusion Criteria
- •Patients with infection at the injection site
- •Coagulopathy Allergy to amide-type local anesthetics
- •History of peripheral neuropathy
- •Hepatic and/or renal failure
- •Refusing the procedure
- •patients with heart disease
Outcomes
Primary Outcomes
24-hour opioid consumption
Time Frame: up to 24 hour
The amount of tramadol consumed in milligrams in the first 24 hours was determined with a patient-controlled analgesia pump.
Secondary Outcomes
- Visual Analog Scale (Vas)(0, 30 minutes, 1 hour, 2 hours, 6 hours, 12 hours, 24 hours)